These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11790297)

  • 41. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
    New RB; Sampson AC; King MK; Hendrick JW; Clair MJ; McElmurray JH; Mandel J; Mukherjee R; de Gasparo M; Spinale FG
    Circulation; 2000 Sep; 102(12):1447-53. PubMed ID: 10993866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure.
    Qiu C; Ding SS; Hess P; Clozel JP; Clozel M
    J Cardiovasc Pharmacol; 2001 Aug; 38(2):317-24. PubMed ID: 11483881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials of endothelin antagonists in heart failure: a question of dose?
    Kelland NF; Webb DJ
    Exp Biol Med (Maywood); 2006 Jun; 231(6):696-9. PubMed ID: 16740982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.
    Sakai S; Miyauchi T; Sakurai T; Kasuya Y; Ihara M; Yamaguchi I; Goto K; Sugishita Y
    Circulation; 1996 Mar; 93(6):1214-22. PubMed ID: 8653844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Endothelin antagonism in heart failure.
    Webb DJ
    Circulation; 1995 Dec; 92(12):3372. PubMed ID: 8521551
    [No Abstract]   [Full Text] [Related]  

  • 49. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
    Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.
    Hefke T; Zittermann A; Fuchs U; Schulte-Eistrup S; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2012 Feb; 60(1):26-34. PubMed ID: 21432755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
    Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
    Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.
    Donckier JE
    Heart Fail Rev; 2001 Dec; 6(4):253-64. PubMed ID: 11447300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic effect of endothelin antagonists in dogs with myocardial infarction.
    Ohta H; Suzuki J; Akima T; Kawai N; Hanada K; Nishikibe M
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S255-7. PubMed ID: 9595453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
    Suresh DP; Lamba S; Abraham WT
    J Card Fail; 2000 Dec; 6(4):359-68. PubMed ID: 11145761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo.
    Holm P; Franco-Cereceda A
    Acta Physiol Scand; 1999 Feb; 165(2):163-8. PubMed ID: 10090327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale and perspective of endothelin-1 antagonism in acute heart failure.
    Kiowski W; Suetsch G; Oechslin E; Schalcher C; Brunner-Larocca HP; Bertel O
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S53-7. PubMed ID: 11811379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
    Fraccarollo D; Hu K; Galuppo P; Gaudron P; Ertl G
    Circulation; 1997 Dec; 96(11):3963-73. PubMed ID: 9403621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.